In our SLE cohort, 27/199 (13.6%) patients were also found to be positive for anti-NT5c1A, 8/199 (4%) had remarkably high titers >10,000 MFU (Figure 2). The gene discussed is NT5C1A; the disease is systemic lupus erythematosus.